Muyu Kuang

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.

First-in-human phase 1/2a study of T3011, an oncolytic HSV expressing IL-12 and PD-1 antibody, administered via intratumoral (IT) injection as monotherapy in advanced solid tumors, including recurrent or metastatic HNSCC.

Journal: BMC medicine

Published: November 28, 2025

Corrigendum to "The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma" [EBioMedicine 51(2020)102598].

Corrigendum to "The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma" [EBioMedicine 51(2020)102598].

Journal: EBioMedicine

Published: December 20, 2021

Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation.

Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation.

Journal: The clinical respiratory journal

Published: April 01, 2021

A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.

A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.

Journal: Genome biology

Published: May 27, 2020

EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis.

EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis.

Journal: Journal of cancer research and clinical oncology

Published: December 10, 2019

FGB and FGG derived from plasma exosomes as potential biomarkers to distinguish benign from malignant pulmonary nodules.

FGB and FGG derived from plasma exosomes as potential biomarkers to distinguish benign from malignant pulmonary nodules.

Journal: Clinical and experimental medicine

Published: March 26, 2019

Genomic and immune profiling of pre-invasive lung adenocarcinoma.

Genomic and immune profiling of pre-invasive lung adenocarcinoma.

Journal: Nature communications

Published: November 30, 2018

The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma.

The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma.

Journal: EBioMedicine

Published: October 14, 2018

tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas.

tRNA-based prognostic score in predicting survival outcomes of lung adenocarcinomas.

Journal: International journal of cancer

Published: September 04, 2018

Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules.

Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules.

Journal: Clinical proteomics

Published: June 08, 2018

Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.

Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.

Journal: American journal of clinical pathology

Published: May 11, 2018

ALCAM+ stromal cells: role in giant cell tumor of bone progression.

ALCAM+ stromal cells: role in giant cell tumor of bone progression.

Journal: Cell death & disease

Published: August 20, 2017

Showing 1-12 of 13

Last Updated: 09/26/2026